Investigation of fatigue, mental well-being and tachycardia in short- and long-term metformin use

dc.contributor.authorAkeren, Zahide
dc.date.accessioned2026-02-28T12:18:10Z
dc.date.available2026-02-28T12:18:10Z
dc.date.issued2025
dc.departmentBayburt Üniversitesi
dc.description.abstractPurpose: The current study aimed compare short and long-term metformin users according to sociodemographic characteristics and to examine the relationships between fatigue, tachycardia and psychological well-being. Materials and Methods: In cross-sectional study were reached 92 patients, 46 short-term and 46 long-term metformin users. It was measured fatigue with the Functional Assessment of Chronic Illness Treatment Fatigue Scale (FACIT-F), tachycardia with saturation device, well-being with the World Health Organization Well-Being Index (WHO-5). Results: For the group using short-term metformin, the mean; year of metformin use was 1.82 +/- 0.77 and pulse rate was 82.48 +/- 8.80, FACIT-F score was 20.37 +/- 7.25, and WHO-5 score was 15.70 +/- 3.23. The group using long-term metformin mean year of metformin use was 5.93 +/- 2.68, pulse rate was 84.57 +/- 9.64, FACIT-F score was 25.33 +/- 5.65 and WHO-5 score was 12.63 +/- 3.70. Well-being negatively correlated with the year of diabetes, year of metformin use, pulse rate and fatigue. FACIT-F, metformin year and pulse rate explain a total of 41.9% of the variance in well-being. FACIT-F ((3=-.51, t=-5.82, p= .000) and the year of metformin use ((3=-.19, t=-2.12, p= .037) significantly decrease well-being, while pulse rate does not have a significant effect on well-being. Conclusions: Long-term use of metformin has been found cause fatigue and negative psychological well-being. Fatigue, year of metformin use and pulse rate number are important predictors of psychological well-being in Type II diabetes patients using metformin.
dc.identifier.doi10.17826/cumj.15892760
dc.identifier.endpage98
dc.identifier.issn2602-3032
dc.identifier.issn2602-3040
dc.identifier.issue1
dc.identifier.startpage90
dc.identifier.trdizinid1308480
dc.identifier.urihttps://doi.org/10.17826/cumj.15892760
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/1308480
dc.identifier.urihttps://hdl.handle.net/20.500.12403/6136
dc.identifier.volume50
dc.identifier.wosWOS:001456063300010
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakTR-Dizin
dc.language.isoen
dc.publisherCukurova Univ, Fac Medicine
dc.relation.ispartofCukurova Medical Journal
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260218
dc.subject. Metformin
dc.subjectmental well-being
dc.subjectfatigue
dc.subjecttachycardia
dc.titleInvestigation of fatigue, mental well-being and tachycardia in short- and long-term metformin use
dc.typeArticle

Dosyalar